V. Ala‐Hurula - Concepedia

Author

V. Ala‐Hurula

University of Oulu

Also Known As

V M Ala-Hurula, V. Ala-Hurula, V. Ala‐Hurula, Veli Ala-Hurula, Veli Ala‐Hurula

Publications

853

Citations

H-Index

Concepts

All Affiliations

University of Oulu Oulu University Hospital Lapland Central Hospital Umeå University Swedish Chemicals Agency

About

V. Ala‐Hurula is an author at University of Oulu specializing in medicine, pharmacology, and anesthesia.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	441
2	Anesthesia	3	3	68
3	Neurology	3	3	350
4	Health Sciences	2	2	29
5	Neuroscience	2	2	340

V. Ala‐Hurula

Publications

848

Citations

H-Index

Page 1

	Year	Citations
Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn-superoxide dismutase Peter M. Andersen, Peter Nilsson, V. Ala‐Hurula, Nature Genetics Amyotrophic Lateral SclerosisCuzn-superoxide DismutaseGenetic DisorderGeneticsNeuroscience	1995	317
Autosomal recessive adult-onset amyotrophic lateral sclerosis associated with homozygosity for Asp90Ala CuZn-superoxide dismutase mutation: A clinical and genealogical study of 36 patients Peter M. Andersen, Lars Forsgren, Michael Binzer, Brain	1996	262
Chromosome 14–encoded Alzheimer's disease: Genetic and clinicopathological description Matti Haltia, Matti Viitanen, Raimo Sulkava, Annals of Neurology	1994	99
Ergotamine Abuse: Results of Ergotamine Discontinuation, With Special Reference To the Plasma Concentrations V. Ala‐Hurula, Vilho V. Myllylä, E. Hokkanen Cephalalgia	1982	46
Systemic availability of ergotamine tartrate after oral, rectal and intramuscular administration V. Ala‐Hurula, V. V. Myllyl�, P. Arvela, European Journal of Clinical Pharmacology MedicineAnesthesiaPharmacologyIntramuscular AdministrationSystemic Availability	1979	39
Systemic availability of ergotamine tartrate after three successive doses and during continuous medication V. Ala‐Hurula, V. V. Myllyl�, P. Arvela, European Journal of Clinical Pharmacology MedicineSystemic AvailabilityClinical PharmacologyPharmacotherapyContinuous Medication	1979	33
Juvenile amyotrophic lateral sclerosis V.V. Myllylä, E. Toivakka, V. Ala‐Hurula, Acta Neurologica Scandinavica Neurodegenerative DiseasesAmyotrophic Lateral SclerosisNeurological DisorderNeuroanatomyNeuromotor Disorders	2009	23
Tolfenamic Acid and Ergotamine Abuse V. Ala‐Hurula, V.V. Myllylä, E. Hokkanen, Headache The Journal of Head and Face Pain Pain DisordersProstaglandin SynthesisPain MedicineTolfenamic AcidPharmacotherapy	1981	19
Correlation between pharmacokinetics and clinical effects of ergotamine in patients suffering from migraine V. Ala‐Hurula European Journal of Clinical Pharmacology Cluster HeadacheHealth SciencesPain MedicineMedicinePharmacotherapy	1982	10

Page 1